CPC
VRTX icon

Cookson Peirce & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Cookson Peirce & Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,719
Closed -$833K – 323
2025
Q1 		$833K Sell
1,719
-146,061
-99% -$68.1M 0.04% 163
2024
Q4 		$59.5M Sell
147,780
-7,301
-5% -$3.38M 2.7% 8
2024
Q3 		$72.1M Sell
155,081
-1,088
-0.7% -$523K 3.38% 4
2024
Q2 		$73.2M Buy
156,169
+13,187
+9% +$5.72M 3.52% 4
2024
Q1 		$59.8M Sell
142,982
-1,026
-0.7% -$434K 3.19% 6
2023
Q4 		$58.6M Sell
144,008
-2,893
-2% -$1.07M 3.54% 5
2023
Q3 		$51.1M Buy
146,901
+333
+0.2% +$116K 3.35% 4
2023
Q2 		$51.6M Buy
146,568
+7,996
+6% +$2.69M 3.15% 6
2023
Q1 		$43.7M Buy
138,572
+19,457
+16% +$5.84M 2.8% 6
2022
Q4 		$34.4M Buy
119,115
+59,543
+100% +$18.1M 2.24% 12
2022
Q3 		$17.2M Buy
59,572
+46,137
+343% +$13.3M 1.22% 35
2022
Q2 		$3.79M Sell
13,435
-784
-6% -$210K 0.26% 75
2022
Q1 		$3.71M Buy
14,219
+682
+5% +$162K 0.22% 82
2021
Q4 		$2.97M Buy
+13,537
New +$2.63M 0.17% 85
2020
Q4 		– Sell
-159,556
Closed -$43.4M – 187
2020
Q3 		$43.4M Buy
159,556
+19,077
+14% +$5.26M 3.26% 4
2020
Q2 		$40.8M Buy
140,479
+1,586
+1% +$430K 3.83% 4
2020
Q1 		$33M Buy
+138,893
New +$31.9M 3.8% 2
2018
Q2 		– Sell
-9,740
Closed -$1.59M – 167
2018
Q1 		$1.59M Buy
9,740
+1,690
+21% +$276K 0.14% 74
2017
Q4 		$1.21M Buy
8,050
+760
+10% +$113K 0.11% 81
2017
Q3 		$1.11M Buy
+7,290
New +$1.1M 0.11% 84

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cookson Peirce & Co's VRTX Position: Q2 2025 in Review

Cookson Peirce & Co sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 1,719 shares — an estimated $833K sold.

Cookson Peirce & Co first reported a position in VRTX in Q3 2017 and held it in 20 quarters. The position peaked at $73.2M in Q2 2024. 1,562 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Cookson Peirce & Co reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cookson Peirce & Co sold 1,719 Vertex Pharmaceuticals shares in Q2 2025, an estimated $833K.
  • Cookson Peirce & Co first reported a position in Vertex Pharmaceuticals in Q3 2017 and held it in 20 quarters.
  • Cookson Peirce & Co's Vertex Pharmaceuticals position peaked at $73.2M in Q2 2024.
  • 1,562 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Cookson Peirce & Co's 13F filing for Q2 2025, filed 30 Jul 2025.